Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

大流行 焦虑 心理健康 2019年冠状病毒病(COVID-19) 医学 重性抑郁障碍 精神科 人口 全球卫生 疾病负担 萧条(经济学) 公共卫生 环境卫生 疾病 传染病(医学专业) 宏观经济学 病理 护理部 经济 认知
作者
Damian Santomauro,Ana Maria Mantilla Herrera,Jamileh Shadid,Peng Zheng,Charlie Ashbaugh,David M. Pigott,Cristiana Abbafati,Christopher Adolph,Joanne O Amlag,Aleksandr Y. Aravkin,Bree Bang-Jensen,Gregory J Bertolacci,Sabina Bloom,Rachel Castellano,Emma Castro,Suman Chakrabarti,Jhilik Chattopadhyay,Rebecca M Cogen,James K. Collins,Xiaochen Dai
出处
期刊:The Lancet [Elsevier BV]
卷期号:398 (10312): 1700-1712 被引量:4140
标识
DOI:10.1016/s0140-6736(21)02143-7
摘要

Summary

Background

Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the mental health impacts of COVID-19 in a way that informs health system responses is imperative. In this study, we aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020.

Methods

We conducted a systematic review of data reporting the prevalence of major depressive disorder and anxiety disorders during the COVID-19 pandemic and published between Jan 1, 2020, and Jan 29, 2021. We searched PubMed, Google Scholar, preprint servers, grey literature sources, and consulted experts. Eligible studies reported prevalence of depressive or anxiety disorders that were representative of the general population during the COVID-19 pandemic and had a pre-pandemic baseline. We used the assembled data in a meta-regression to estimate change in the prevalence of major depressive disorder and anxiety disorders between pre-pandemic and mid-pandemic (using periods as defined by each study) via COVID-19 impact indicators (human mobility, daily SARS-CoV-2 infection rate, and daily excess mortality rate). We then used this model to estimate the change from pre-pandemic prevalence (estimated using Disease Modelling Meta-Regression version 2.1 [known as DisMod-MR 2.1]) by age, sex, and location. We used final prevalence estimates and disability weights to estimate years lived with disability and disability-adjusted life-years (DALYs) for major depressive disorder and anxiety disorders.

Findings

We identified 5683 unique data sources, of which 48 met inclusion criteria (46 studies met criteria for major depressive disorder and 27 for anxiety disorders). Two COVID-19 impact indicators, specifically daily SARS-CoV-2 infection rates and reductions in human mobility, were associated with increased prevalence of major depressive disorder (regression coefficient [B] 0·9 [95% uncertainty interval 0·1 to 1·8; p=0·029] for human mobility, 18·1 [7·9 to 28·3; p=0·0005] for daily SARS-CoV-2 infection) and anxiety disorders (0·9 [0·1 to 1·7; p=0·022] and 13·8 [10·7 to 17·0; p<0·0001]. Females were affected more by the pandemic than males (B 0·1 [0·1 to 0·2; p=0·0001] for major depressive disorder, 0·1 [0·1 to 0·2; p=0·0001] for anxiety disorders) and younger age groups were more affected than older age groups (−0·007 [–0·009 to −0·006; p=0·0001] for major depressive disorder, −0·003 [–0·005 to −0·002; p=0·0001] for anxiety disorders). We estimated that the locations hit hardest by the pandemic in 2020, as measured with decreased human mobility and daily SARS-CoV-2 infection rate, had the greatest increases in prevalence of major depressive disorder and anxiety disorders. We estimated an additional 53·2 million (44·8 to 62·9) cases of major depressive disorder globally (an increase of 27·6% [25·1 to 30·3]) due to the COVID-19 pandemic, such that the total prevalence was 3152·9 cases (2722·5 to 3654·5) per 100 000 population. We also estimated an additional 76·2 million (64·3 to 90·6) cases of anxiety disorders globally (an increase of 25·6% [23·2 to 28·0]), such that the total prevalence was 4802·4 cases (4108·2 to 5588·6) per 100 000 population. Altogether, major depressive disorder caused 49·4 million (33·6 to 68·7) DALYs and anxiety disorders caused 44·5 million (30·2 to 62·5) DALYs globally in 2020.

Interpretation

This pandemic has created an increased urgency to strengthen mental health systems in most countries. Mitigation strategies could incorporate ways to promote mental wellbeing and target determinants of poor mental health and interventions to treat those with a mental disorder. Taking no action to address the burden of major depressive disorder and anxiety disorders should not be an option.

Funding

Queensland Health, National Health and Medical Research Council, and the Bill and Melinda Gates Foundation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
逍遥完成签到,获得积分10
刚刚
小明完成签到,获得积分10
1秒前
小野狼完成签到,获得积分10
2秒前
夜猫完成签到,获得积分10
2秒前
Orange应助严西采纳,获得10
2秒前
2秒前
有点小卑鄙完成签到,获得积分10
2秒前
wyw123完成签到,获得积分10
2秒前
haibing发布了新的文献求助10
2秒前
cc完成签到,获得积分20
3秒前
落寞冬云完成签到,获得积分10
4秒前
小团子完成签到 ,获得积分10
4秒前
梧桐雨210完成签到,获得积分10
4秒前
唠叨的雪糕完成签到,获得积分10
5秒前
小雨完成签到,获得积分10
5秒前
矜天完成签到 ,获得积分10
6秒前
6秒前
6秒前
6秒前
jjeuchi发布了新的文献求助20
7秒前
Lenacici完成签到,获得积分10
7秒前
burno1112完成签到,获得积分10
8秒前
冰激凌完成签到,获得积分10
9秒前
犹豫的初丹完成签到,获得积分10
9秒前
啦啦啦完成签到,获得积分10
9秒前
9秒前
Rling完成签到,获得积分10
9秒前
纷纭完成签到,获得积分10
10秒前
李雨泽完成签到,获得积分10
11秒前
suchui完成签到,获得积分10
12秒前
心斋完成签到,获得积分10
12秒前
科目三应助luoshikun采纳,获得30
12秒前
12秒前
NexusExplorer应助杨惠文采纳,获得10
13秒前
13秒前
江海客完成签到,获得积分10
13秒前
想早点退休完成签到,获得积分10
13秒前
哈哈发布了新的文献求助10
13秒前
lll完成签到,获得积分10
13秒前
请勿继续完成签到,获得积分10
14秒前
高分求助中
【请各位用户详细阅读此贴后再求助】科研通的精品贴汇总(请勿应助) 10000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 500
Maritime Applications of Prolonged Casualty Care: Drowning and Hypothermia on an Amphibious Warship 500
Comparison analysis of Apple face ID in iPad Pro 13” with first use of metasurfaces for diffraction vs. iPhone 16 Pro 500
Towards a $2B optical metasurfaces opportunity by 2029: a cornerstone for augmented reality, an incremental innovation for imaging (YINTR24441) 500
Materials for Green Hydrogen Production 2026-2036: Technologies, Players, Forecasts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4061661
求助须知:如何正确求助?哪些是违规求助? 3600275
关于积分的说明 11433299
捐赠科研通 3323815
什么是DOI,文献DOI怎么找? 1827483
邀请新用户注册赠送积分活动 897954
科研通“疑难数据库(出版商)”最低求助积分说明 818774